SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

INM

InMed Pharmaceuticals Inc.
NASDAQHealth Care

Latest close: 1.32 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Reported purchase · Form 4ADAR1 Capital Management, LLC · $1.3KOpen the filing ↗
  2. Oct 14, 2026Reported purchase · Form 4ADAR1 Capital Management, LLC · $10.7KOpen the filing ↗
  3. Oct 13, 2026Reported purchase · Form 4ADAR1 Capital Management, LLC · $750.1Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record46717 flagged findings
Reported transactions (Form 4)80since Dec 23, 2023 · and 5 other holdings
Corporate events (8-K)30since Nov 22, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-10listing compliance noticerecentOpen filing ↗
    “…11, 2026 to March 26, 2026 period. On June 3, 2026, the Company received written notice from Nasdaq informing the Company that,…”
    +1 more passage from the same document
    • “…June 2, 2026, the closing bid price of the Company's common shares had been at or above $1.00 per share. Accordingly, the Company…”
  • 2026-05-19listing compliance noticerecentOpen filing ↗
    “…Each of the Company and Mentari has made customary representations, warranties and covenants in the Merger Agreement, including,…”
  • 2026-05-19merger or acquisition eventrecentOpen filing ↗
    “…and a wholly owned subsidiary of the Company (the “ First Merger Sub ”), Indigo Merger Sub II, LLC, a Delaware limited liability…”
    +1 more passage from the same document
    • “…of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has…”
  • 2026-05-19reverse splitrecentOpen filing ↗
    “…more than 20% of the Company’s outstanding Common Shares and the resulting change of control pursuant to Nasdaq rules, and…”
  • 2026-05-19reverse splitrecentOpen filing ↗
    “…from the Company up to 278,761 common shares in the capital of the Company at an exercise price per common share of $16.60,…”
  • 2026-05-06share offering or dilution eventrecentOpen filing ↗
    “…Under the terms of the SEPA, the Company paid the Investor a one-time structuring fee in the amount of $ 25,000 in December…”
  • 2026-05-06listing compliance noticerecentOpen filing ↗
    “…Developments NASDAQ Delisting Notice As previously reported, on March 27, 2026, we received a written notice from the Listing…”
    +1 more passage from the same document
    • “…reported, on March 27, 2026, we received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC,…”
  • 2026-05-06reverse splitrecentOpen filing ↗
    “…qualify, we will be required to meet the continued listing requirement for market value of publicly held shares and all other…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 467)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 2 Form 4 filings newshow all 2hide
  • Oct 7, 26SCHEDULE 13G/A ↗Passive stake · ADAR1 Capital Management, LLC · 17.2% · event on Sep 30, 26 · amendment
  • Oct 5, 26Form 4 ↗Insider transaction
  • Oct 1, 26424B3 ↗Securities offering
  • Sep 29, 26S-4/A ↗Merger, acquisition or tender offer · amendment
  • Sep 18, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Sep 16, 26Form 4 ↗Insider transaction
  • Sep 9, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 9, 2610-K ↗Annual report
  • Sep 9, 26S-4/A ↗Merger, acquisition or tender offer · amendment
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Ikarian Capital, LLC · 4.2% · event on Jun 30, 26
  • Jul 22, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 22, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 22, 268-K ↗Current report · Communication to the market · Other events
  • Jul 20, 26Form 425 ↗Merger, acquisition or tender offer
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jul 10, 26Form 425 ↗Merger, acquisition or tender offer
  • Jul 10, 268-K ↗Current report · Entered a material agreement
  • Jul 2, 26Form 4 ↗Insider transaction
  • Jul 2, 26S-4 ↗Merger, acquisition or tender offer
  • Jun 10, 26SCHEDULE 13D ↗Stake with intent to influence · Vivo Opportunity Fund Holdings, L.P. · 21.7% · event on May 19, 26
  • Jun 10, 26Form 4 ↗Insider transaction
  • Jun 10, 26Form 3 ↗Insider transaction

467 filings on record, the oldest from May 12, 20.

Listing the 25 most recent filings of the 467 on record.

8-Ks, explained

Stress9Structure29Governance18
  • Sep 18, 26StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Structure4 material agreements entered2026show all 4hide
    • Jul 10, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • May 19, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • May 19, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Apr 27, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 30, 26StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Mar 6, 26StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Oct 16, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Oct 14, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 30, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jun 13, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Feb 14, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Dec 18, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Nov 5, 24StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Sep 20, 24StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗

8 older filings not shown · The record reaches back to Nov 12, 20.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 9 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Vivo Opportunity Fund Holdings, L.P.21.7%May 19, 26SCHEDULE 13D ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • ADAR1 Capital Management, LLC17.2%Sep 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • YA II PN, Ltd.10.0%Dec 13, 24SCHEDULE 13G ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
  • SABBY MANAGEMENT, LLC9.9%Dec 31, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Squadron Master Fund LP9.8%May 19, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Ikarian Capital, LLC4.2%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 15, 26Buy$1KADAR1 Capital Management, LLC↗
  • Oct 14, 26Buy$11KADAR1 Capital Management, LLC↗
  • Oct 13, 26Buy$750ADAR1 Capital Management, LLC↗
  • Oct 8, 26Buy$3KADAR1 Capital Management, LLC↗
  • Oct 7, 26Buy$4KADAR1 Capital Management, LLC↗
  • Oct 6, 26Buy$7KADAR1 Capital Management, LLC↗
  • Oct 5, 26Buy$24KADAR1 Capital Management, LLC↗
  • Oct 2, 26Buy$11KADAR1 Capital Management, LLC↗
  • Oct 1, 26Buy$22KADAR1 Capital Management, LLC↗
  • Sep 16, 26Buy$11KADAR1 Capital Management, LLC↗
  • Sep 15, 26Buy$70KADAR1 Capital Management, LLC↗
  • Sep 14, 26Buy$37KADAR1 Capital Management, LLC↗

There are 28 more transactions in this stretch.

The full record holds 49 transactions and goes back to Mar 8, 23.

Its sector and its market

InMed Pharmaceuticals Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From InMed Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow InMed Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
467 documents on file, from May 12, 2020 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 18, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.